â– LECTURE OVERVIEW: Neonatal Jaundice (hyperbilirubinemia) is a common clinical finding, classified chronologically into physiological and pathological profiles.
â– THE DYNAMIC SPLITS:
1. Physiological Jaundice (Normal/Benign):
- Pathogenesis: Caused by a transient, relative deficiency of hepatic UDP-glucuronosyltransferase (UGT) activity in a neonate with high red cell turnover.
- Timeline: Arises after the first 24 hours of life, peaking on days 3-5 before resolving.
2. Pathological Jaundice (Diseased):
- Pathogenesis: Driven by hemolysis (e.g., Rh/ABO incompatibility), biliary atresia, or sepsis.
- Timeline: Begins within the first 24 hours of life. Bilirubin levels rise quickly (>5 mg/dL/day or >15 mg/dL total).
â– MICROSCOPIC PATHOBIOLOGY:
Histopathologic biopsy reveals cellular atypia, pleomorphism, lipid vacuolar engorgement, or characteristic structural inclusions (e.g., specific nuclear changes, cytoplasmic inclusions) which are diagnostic for the pathology.
â– PEDIATRIC CONTEXT & CONTINGENCIES:
Developing cohorts present with high body-water percentages and dynamic hepatic enzyme maturation pathways.
[HY-BOARD-1146]
🌟 Dynamic Clinical Key:
In pathological jaundice, high levels of unconjugated (indirect) bilirubin can cross the blood-brain barrier. Bilirubin deposits selectively in the basal ganglia, predisposing the neonate to acute bilirubin encephalopathy or permanent, devastating Kernicterus. Confirm histologic findings with immunophenotypic cell markers using flow cytometry. Always utilize body-surface-area or weight-based dosing calculators for pediatric populations.